This page shows the publications co-authored by Robert Green and Lisa Lehmann.
Navigating a research partnership between academia and industry to assess the impact of personalized genetic testing. Genet Med. 2012 Feb; 14(2):268-73.
Genomic medicine in primary care: barriers and assets. Postgrad Med J. 2013 Nov; 89(1057):615-6.
Navigating the research-clinical interface in genomic medicine: analysis from the CSER Consortium. Genet Med. 2018 04; 20(5):545-553.
Consumer Perspectives on Access to Direct-to-Consumer Genetic Testing: Role of Demographic Factors and the Testing Experience. Milbank Q. 2017 06; 95(2):291-318.
Patients' perceived utility of whole-genome sequencing for their healthcare: findings from the MedSeq project. Per Med. 2016 Jan 01; 13(1):13-20.
Are physicians prepared for whole genome sequencing? a qualitative analysis. Clin Genet. 2016 Feb; 89(2):228-34.
'Someday it will be the norm': physician perspectives on the utility of genome sequencing for patient care in the MedSeq Project. Per Med. 2015; 12(1):23-32.
The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicine. Trials. 2014 Mar 20; 15:85.
Health-care referrals from direct-to-consumer genetic testing. Genet Test Mol Biomarkers. 2010 Dec; 14(6):817-9.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.